Publication:
Pap smear screening in the primary health care setting: A study from Turkey

dc.contributor.buuauthorMehmetoğlu, Hande Çelik
dc.contributor.buuauthorSadıkoğlu, Ganime
dc.contributor.buuauthorÖzcakır, Alis
dc.contributor.buuauthorÖZÇAKIR, ALİS
dc.contributor.buuauthorBilgel, Nazan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentAile Hekimliği Ana Bilim Dalı
dc.contributor.orcid0000-0002-4539-5849
dc.contributor.researcheridAAG-8209-2021
dc.date.accessioned2024-09-28T12:05:06Z
dc.date.available2024-09-28T12:05:06Z
dc.date.issued2010-10-01
dc.description.abstractBackground: Cervical cancer is one of the ten most frequent cancers in Turkey. It is well known that cervical cancer morbidity and mortality could be significantly reduced with an active cervical smear screening (Pap smear) program. Aims: The aims of this study were: 1) to evaluate the knowledge and attitudes of women about cervical smear testing; 2) to establish a cervical smear screening program and to evaluate the cervical cytological abnormalities that were found; 3) to determine the applicability, limitations and effectiveness of this screening in a primary health care unit. Patients and Methods : A total of 332 married women were included in our study. We collected data concerning socio-demographic and fertility characteristics, and knowledge about Pap smear testing was determined through printed questionnaires. A gynecological examination and Pap smear screening was performed on every woman in our study group. Results: Over ninety percent of our study group had never heard of and had not undergone Pap smear screening before. Of the 332 smears evaluated, 328 (98.8%) were accepted as normal, whereas epithelial cell anomalies were seen in 4 (1.2%), infection in 59 (17.7%), and reactive cell differences in 223 (67.2%) of the smears. Conclusions: The frequency of epithelial cell anomalies in our study group was less than the frequencies reported from Western countries. Knowledge regarding cervical cancer and Pap smear screening was very low. Pap smears can be easily taken and evaluated through a chain built between the primary health care unit and laboratory, and this kind of screening intervention is easily accepted by the population served.
dc.identifier.doi10.4297/najms.2010.2468
dc.identifier.endpage472
dc.identifier.issn2250-1541
dc.identifier.issue10
dc.identifier.startpage467
dc.identifier.urihttps://doi.org/10.4297/najms.2010.2468
dc.identifier.urihttps://hdl.handle.net/11452/45427
dc.identifier.volume2
dc.identifier.wos000219191300004
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherMedknow Publications & Media Pvt Ltd
dc.relation.journalNorth American Journal Of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCervical smear
dc.subjectCervical intraepithelial lesion
dc.subjectCervical cancer screening
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectMedicine, general & internal
dc.subjectGeneral & internal medicine
dc.titlePap smear screening in the primary health care setting: A study from Turkey
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Aile Hekimliği Ana Bilim Dalı
relation.isAuthorOfPublication12eb8574-de66-4d44-a7ed-aec3dd08afe4
relation.isAuthorOfPublication.latestForDiscovery12eb8574-de66-4d44-a7ed-aec3dd08afe4

Files